{
    "1664995350904537089": {
        "author_id": "5383942",
        "created_at": "2023-06-03T14:00:00.000Z",
        "edit_history_tweet_ids": [
            "1664995350904537089"
        ],
        "entities": {
            "annotations": [
                {
                    "end": 57,
                    "normalized_text": "GSK",
                    "probability": 0.5376,
                    "start": 55,
                    "type": "Organization"
                },
                {
                    "end": 80,
                    "normalized_text": "Bob Palumbo",
                    "probability": 0.7683,
                    "start": 70,
                    "type": "Person"
                },
                {
                    "end": 94,
                    "normalized_text": "Susie Barnes",
                    "probability": 0.8546,
                    "start": 83,
                    "type": "Person"
                },
                {
                    "end": 109,
                    "normalized_text": "Roger Levy",
                    "probability": 0.9555,
                    "start": 100,
                    "type": "Person"
                },
                {
                    "end": 229,
                    "normalized_text": "EULAR2023",
                    "probability": 0.5368,
                    "start": 221,
                    "type": "Other"
                }
            ],
            "hashtags": [
                {
                    "end": 230,
                    "start": 220,
                    "tag": "EULAR2023"
                }
            ]
        },
        "id": "1664995350904537089",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 0,
            "impression_count": 3514,
            "like_count": 11,
            "quote_count": 0,
            "reply_count": 1,
            "retweet_count": 1
        },
        "text": "We\u2019re working to advance precision medicine. Hear from GSK Colleagues Bob Palumbo, Susie Barnes and Roger Levy on how researching biologics could represent important advances in the treatment of immune-mediated disease. #EULAR2023"
    }
}